By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    Cognitive Psychology and Risk-taking in Extreme Sports
    Theodore Rex Walrond Highlights the Connection between Cognitive Psychology and Healthcare
    April 1, 2025
    stress management for healthcare workers
    3 Tips For Healthcare Professionals: How To Stay Beautiful, Healthy, and Happy
    November 2, 2021
    importance of relaxing on the weekend for your health
    Importance of Relaxing During the Weekend for Optimal Health
    March 25, 2022
    Latest News
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Image
    Person-Centered HealthCare: The FDA Gets Patient-Centric
    May 31, 2013
    Does the Supreme Court Understand Health Reform?
    April 12, 2012
    Racial Health Disparities Among People with Chronic Conditions in the US: Facts and Statistics
    July 25, 2013
    Latest News
    Top HIPAA-Compliant Messaging Apps for Healthcare Teams
    June 25, 2025
    When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
    June 20, 2025
    Preventing Contamination In Healthcare Facilities Starts With Hygiene
    June 15, 2025
    Strengthening Healthcare Systems Through Clinical and Administrative Career Development
    June 13, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: New Weight Loss Drugs Come to Market as AMA Recognizes Obesity as Disease
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > New Weight Loss Drugs Come to Market as AMA Recognizes Obesity as Disease
Public Health

New Weight Loss Drugs Come to Market as AMA Recognizes Obesity as Disease

Jennifer Bragg
Last updated: October 11, 2013 9:40 am
Jennifer Bragg
Share
5 Min Read
obesity recognized as disease
SHARE

obesity recognized as diseaseOver the summer, the American Medical Association officially labeled obesity a disease. The new designation informed 78 million American adults and 12 million American children that they have a condition requiring medical treatment.

obesity recognized as diseaseOver the summer, the American Medical Association officially labeled obesity a disease. The new designation informed 78 million American adults and 12 million American children that they have a condition requiring medical treatment.

If obesity is, in fact, a disease, the majority of Americans have it. Over one third of Americans are obese and well over two-thirds are overweight. And here in the U.S., we treat diseases with drugs. Coincidentally, two new drugs, Belviq and Qsymia, entered the market shortly after the AMA began calling obesity a disease. These drugs are the first weight loss medications to receive FDA approval in over a decade.

Until very recently, much of the medical community considered weight loss drugs to be vanity products. However, with the rise in obesity in the United States comes a rise in heart disease, depression, type 2 diabetes and some cancers. These drugs may have the potential to prevent the onset of some of these conditions.

More Read

Cool Infographic: Obesity Around The World: New Year’s Resolution, Anyone?
HIMSS Privacy and Security Forum: Managing Social Media While Protecting Privacy and Security
High Reliability Boot Camp: Preparing for Zero Preventable Harm
Communication and Engagement Helped Minn. Hospitals Cut Avoidable Readmissions
Are You Ready for Bundled Payments?

Belviq and Qsymia are recommended for patients with similar problems. Both are recommended for obesity, or a body mass index higher than 30. If you are overweight, with a body mass index of 27 or higher, most doctors will recommend that you have type 2 diabetes, high blood pressure or high cholesterol before using either medication. Pregnant women should not take these drugs.

The major difference between Belviq and most other weight loss drugs or weight management aids is that it actually provides a feeling of satiety. The drug works on serotonin transmitters in the brain to make users feel full. They simply don’t have to eat as much as they would without it.

Qsymia combines two currently approved drugs. The first is an appetite suppressant called phentermine. This is the safer part of the infamous fen-phen weight loss aid. The other half is a seizure and/or migraine drug called topiramate, which can cause feelings of fullness, and increase calorie burning.

“Obesity threatens the overall well being of patients and is a major public health concern,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research in a press release. “Qsymia, used responsibly in combination with a healthy lifestyle that includes a reduced-calorie diet and exercise, provides another treatment option for chronic weight management in Americans who are obese or are overweight and have at least one weight-related comorbid condition.”

Neither Belviq nor Qsymia is a miracle cure. Weight loss with both drugs is moderate for most users. Patients in clinical trials went from an average 227 pounds to 204 pounds on Qsymia. On Belviq, patients’ average weight dropped from 220 to 207.

About 47 percent of Belviq users without type 2 diabetes lost at least 5 percent of their body weight compared with about 23 percent of patients treated with placebo. In users with type 2 diabetes, about 38 percent of patients treated with Belviq and 16 percent treated with placebo lost at least 5 percent of their body weight. Belviq labeling recommends that drug use be discontinued in patients fail to lose 5 percent of their body weight after 12 weeks of treatment, as these patients are unlikely to achieve clinically meaningful weight loss with continued treatment.

Diet drugs have been around in different forms for years. It will likely take years to see if either of these new drugs makes a dent in America’s obesity epidemic.

(obesity / shutterstock)

TAGGED:obesityPerson-Centered HealthCare
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

women dental care
What Is a Smile Makeover and How Much Does It Cost?
Dental health
June 30, 2025
HIPAA-Compliant Messaging Apps
Top HIPAA-Compliant Messaging Apps for Healthcare Teams
Global Healthcare Policy & Law Technology
June 25, 2025
recovering from injury
Rebuilding After Injury: Path to Physical and Emotional Recovery
News
June 22, 2025
scientist using microscope
When Healthcare Ends, the Legal Process Begins: What Families Should Know About Probate and Medical Estates
Global Healthcare
June 18, 2025

You Might also Like

medicare data release
BusinessFinanceHealth ReformHospital AdministrationPolicy & LawPublic Health

Medicare’s Data Release Places More Power in Hands of Informed Medical Consumers

May 9, 2013

NSAIDs Linked to Erectile Dysfunction

April 8, 2011

How Reframing a Problem Can Help Fix HealthCare: Patient Self-Management

January 12, 2012

Positive Health and the Heart

July 28, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?